Your browser doesn't support javascript.
Epidemiology and clinical course of COVID-19 in Shanghai, China.
Shen, Yinzhong; Zheng, Fang; Sun, Danfeng; Ling, Yun; Chen, Jun; Li, Feng; Li, Tao; Qian, Zhiping; Zhang, Yuyi; Xu, Qingnian; Liu, Li; Huang, Qin; Shan, Fei; Xu, Lie; Wu, Jun; Zhu, Zhaoqin; Song, Zhigang; Li, Shenyang; Shi, Yuxin; Zhang, Jianliang; Wu, Xueyun; Mendelsohn, Joshua B; Zhu, Tongyu; Lu, Hongzhou.
  • Shen Y; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Zheng F; Department of Medical Affairs, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Sun D; Department of Medical Affairs, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Ling Y; Department of Infection, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Chen J; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Li F; Department of Respiratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Li T; Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Qian Z; Department of Severe Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhang Y; Department of Severe Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xu Q; Department of Traditional Chinese Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Liu L; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Huang Q; Department of Infection, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Shan F; Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Xu L; Department of Medical Affairs, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Wu J; Department of Medical Affairs, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Zhu Z; Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Song Z; P3 Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Li S; Data Management Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Shi Y; Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Zhang J; Department of Gastroenterology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Wu X; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Mendelsohn JB; College of Health Professions, Pace University, New York, NY, USA.
  • Zhu T; Department of Urology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Lu H; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 9(1): 1537-1545, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-611841
ABSTRACT

Background:

Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai.

Methods:

We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020.

Results:

47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days.

Conclusion:

COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Emerg Microbes Infect Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Emerg Microbes Infect Year: 2020 Document Type: Article